Übersetzung für 'DNA vaccine' von Englisch nach Deutsch

DNA vaccine

DNA-Vakzine {f}med.pharm.

DNA-Impfstoff {m}med.pharm.

---

Werbung

human papillomavirus vaccine <HPV vaccine>

humaner Papillomavirus-Impfstoff {m} <HPV-Impfstoff>pharm.

DNA methyltransferase <DNA MTase>

DNA-Methyltransferase {f} <DNA-MTase>biochem.

vaccine

Impfstoff {m}med.pharm.

Vakzine {f}med.pharm.

Vakzin {n}med.pharm.

Schutzstoff {m} [Impfstoff]med.pharm.

porcine vaccine

Schweineimpfstoff {m}pharm.

experimental vaccine

Versuchsimpfstoff {m}pharm.

experimenteller Impfstoff {m}pharm.

vaccine candidate

Vakzinkandidat {m}pharm.

Impfstoffkandidat {m}med.

candidate vaccine

Versuchsimpfstoff {m} [Vakzinkandidat]pharm.

vaccine drops

Impftropfen {pl}med.

attenuated vaccine

Lebendimpfstoff {m}pharm.

autogenous vaccine

bestandsspezifischer Impfstoff {m}VetMed.

vaccine damage

Impfschaden {m}med.

vaccine development

Impfstoffentwicklung {f}med.

vaccine injury

Impfschaden {m}med.

malaria vaccine

Malariavakzine {f}med.pharm.

vaccine manufacturer

Impfstoffhersteller {m}ind.pharm.

• HMGB1 has been proposed as a DNA vaccine adjuvant. Thus impairment of HMGB1 function appears to have a key role in the pathogenesis of SCA1.
• The DDMM regimen consists of priming with two doses of the pGA2/JS7 recombinant DNA vaccine and boosting with two doses of VA/HIV62B recombinant MVA vaccine.
• Scientists at Vaccine and Immunotherapy Center at The Wistar Institute have designed and tested the first-of-its-kind synthetic DNA vaccine candidate against Powassan virus (POWV), targeting portions of the virus envelope protein.
• By using an oral DNA vaccine carried in an attenuated non-virulent form of Salmonella typhimurium, which co-encoded secretory chemokine CCL21 and survivin protein in C57BL/6J mice, Xiang "et al."
• In Canada, a licensed DNA vaccine against Infectious hematopoietic necrosis has been launched for industry use.

• Because priming with a naked DNA vaccine and boosting with a viral vector results in a robust immune response via yet indefinite mechanism(s), despite pre-existing viral vector immunity, this vaccination strategy can counteract this problem.
• A hybrid vehicle composed of bacteria cell and synthetic polymers has been employed for DNA vaccine delivery.
• During the COVID-19 pandemic Durrant and collaborators from the University of Nottingham and Nottingham Trent University created two COVID-19 vaccines based on the ImmunoBody DNA vaccine platform.
• The two vaccine candidates in this trial are “a protein subunit vaccine from Medigen, and a DNA vaccine encoding the spike protein from Inovio.” More countries are expected to join the program.
• Inovio INO-4800 was chosen as the first DNA Vaccine to be introduced in the largest vaccine trial in history.

• Liposome-based DNA vaccine developed by Dr. Owais has shown remarkable promise against experimental murine brucellosis.
• The DNA vaccine expressed the SARS-CoV2 spike protein once inside human cells to elicit an immune response.
• A Phase 1b/2a trial is underway combining durvalumab with an HPV DNA vaccine (MEDI 0457) in patients with HPV-associated recurrent/metastatic head and neck cancer.
• A major goal recently in HIV-1 vaccinations is eliciting the broadly neutralizing antibodies before the virus is actually established, since the virus integrates itself into the host's DNA. Vaccine trials have been largely unsuccessful in eliciting a response using mimics of the e"nv" region, potentially because of its high genetic variability.
• RNA vaccines and DNA vaccines are examples of third generation vaccines.